Cited by 1,089Genetic Neurodegenerative DiseasesGenetic factors in colorectal cancerGenetics and Neurodevelopmental Disorders

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Trinucleotide repeat length instability and age of onset in Huntington's disease

Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., Gray, J., Conneally, P., Young, A., Penney, J., Hollingsworth, Z., Shoulson, I., Lazzarini, A., Falek, A., Koroshetz, W., Sax, D., Bird, E., Vonsattel, J., Bonilla, E., Alvir, J., Bickham Conde, J., Cha, J.-H., Dure, L., Gomez, F., Ramos, M., Sanchez-Ramos, J., Snodgrass, S., de Young, M., Wexler, N., Moscowitz, C., Penchaszadeh, G., MacFarlane, H., Anderson, M., Jenkins, B., Srinidhi, J., Barnes, G., Gusella, J., MacDonald, M.·1993·Nature Genetics

DOI 10.1038/ng0893-387

Open this paper in CoChat — free account

Abstract

The initial observation of an expanded and unstable trinucleotide repeat in the Huntington's disease gene has now been confirmed and extended in 150 independent Huntington's disease families. HD chromosomes contained 37-86 repeat units, whereas normal chromosomes displayed 11-34 repeats. The HD repeat length was inversely correlated with the age of onset of the disorder. The HD repeat was unstable in more than 80% of meiotic transmissions showing both increases and decreases in size with the largest increases occurring in paternal transmissions. The targeting of spermatogenesis as a particular source of repeat instability is reflected in the repeat distribution of HD sperm DNA. The analysis of the length and instability of individual repeats in members of these families has profound implications for presymptomatic diagnosis.

Integrity signals

Registry

Crossref · 10.1038/ng0893-387

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Self-citation
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Self-citation
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801
Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754
A polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K. A., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,340
Self-citation
Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox
Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Myotonic Dystrophy Mutation: an Unstable CTG Repeat in the 3′ Untranslated region of the Gene
Mahadevan, M. S., Tsilfidis, C., Sabourin, L. A., Shutler, G., Amemiya, C. T., Jansen, G., Neville, C., Narang, M. A., Barceló, J. M., O'Hoy, K., et al. (1992) · Science · doi:10.1126/science.1546325 · Cited by 1,656
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
Orr, H. T., Chung, M.-Y., Banfi, S., Kwiatkowski, T. J., Servadio, A., Beaudet, A. L., McCall, A. E., Duvick, L. A., Ranum, L. P. W., & Zoghbi, H. Y. (1993) · Nature Genetics · doi:10.1038/ng0793-221 · Cited by 1,632
An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,453

Flagged first, then by citations

Show all 35 references

Research works printed but not linked: 1

SAS/STAT User's Guide, Version 6, 4th edn, Vol.2 (SAS Institute Inc., Cary, North Carolina, 1989).

Sorted by citations

Items 601–700 of 998

Hunting for the cause: Evidence for prion-like mechanisms in Huntington’s disease
Donnelly, K. M., Coleman, C. M., Fuller, M. L., Reed, V. L., Smerina, D., Tomlinson, D. S., & Pearce, M. M. P. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.946822 · Cited by 20
Abnormal Weight and Body Mass Index in Children with Juvenile Huntington’s Disease
Tereshchenko, A., McHugh, M. A., Lee, J. K., Gonzalez‐Alegre, P., Crane, K., Dawson, J. D., & Nopoulos, P. (2015) · Journal of Huntington s Disease · doi:10.3233/jhd-150152 · Cited by 20
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington’s disease
Lee, J. H., Lee, J., Ramos, E. M., Gillis, T., Mysore, J. S., Kishikawa, S., Hadzi, T. C., Hendricks, A. E., Hayden, M. R., Morrison, P. J., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.120 · Cited by 20
Self-citation
The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease
Klempíř, J., Židovská, J., Štochl, J., Kebrdlová, V., Uhrová, T., & Roth, J. (2010) · Movement Disorders · doi:10.1002/mds.23436 · Cited by 20
Natural biological variation of white matter microstructure is accentuated in Huntington's disease
Gregory, S., Crawford, H. E., Seunarine, K. K., Leavitt, B. R., Dürr, A., Roos, R. A. C., Scahill, R. I., Tabrizi, S. J., Rees, G. E., Langbehn, D. R., et al. (2018) · Human Brain Mapping · doi:10.1002/hbm.24191 · Cited by 20
Neural Transplants From Human Induced Pluripotent Stem Cells Rescue the Pathology and Behavioral Defects in a Rodent Model of Huntington’s Disease
Yoon, Y., Kim, H. S., Hong, C. P., Li, E., Jeon, I., Park, H. J., Lee, N., Pei, Z., & Song, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.558204 · Cited by 19
Onset and Progression of Behavioral and Molecular Phenotypes in a Novel Congenic R6/2 Line Exhibiting Intergenerational CAG Repeat Stability
Cowin, R.-M., Bui, N., Graham, D. F., Green, J. R., Grueninger, S., Yuva‐Paylor, L. A., Syed, A. U., Weiss, A., & Paylor, R. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028409 · Cited by 20
No evidence of association between BDNF gene variants and age-at-onset of Huntington's disease
Maria, E. D., Marasco, A., Tartari, M., Ciotti, P., Abbruzzese, G., Novelli, G., Bellone, E., Cattaneo, E. F., & Mandich, P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.002 · Cited by 20
NMDA Receptors and Huntington’s Disease
Fernandes, H. B., & Raymond, L. A. (2008) · Frontiers in neuroscience · doi:10.1201/9781420044157.ch2 · Cited by 21
Chemical architecture of the basal ganglia
Graybiel, A. M., & Penney, J. B. (1999) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(99)80025-6 · Cited by 20
Self-citation
Gene therapy and pharmacological treatment of inherited neurological disorders
Martin, J. B. (1995) · Trends in biotechnology · doi:10.1016/s0167-7799(00)88898-8 · Cited by 20
Deficits in stepping response time are associated with impairments in balance and mobility in people with Huntington disease
Goldberg, A., Niemiec, S. L. S., Feely, S. M. E., Garbern, J. Y., Miller, L. J., Siskind, C. E., & Conti, G. E. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.002 · Cited by 19
Huntington’s Disease: Clinical Features and Routes to Therapy
Paulson, H. L., & Albin, R. L. (2011) · Europe PMC (PubMed Central) · Cited by 19
Therapeutic potential of ginsenoside Rg3 and Rf for Huntington’s disease
Lee, M., Ban, J., Won, B. H., Im, W., & Kim, M. (2021) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-021-00595-1 · Cited by 20
CAG repeat length and disease duration in Machado-Joseph disease: a new clinical classification
Maruyama, H., Kawakami, H., Kohriyama, T., Sakai, T., Doyu, M., Sobue, G., Seto, M., Tsujihata, M., Ohi, T., Nishio, T., et al. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00155-x · Cited by 19
Dentatorubropallidoluysian Atrophy in Chinese
Lee, I. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1905 · Cited by 19
Machado–Joseph disease in three Scandinavian families
Løkkegaard, T., Nielsen, J. E., Hasholt, L., Fenger, K., Werdelin, L., Tranebjærg, L., Lauritzen, M., Colding‐Jørgensen, E., Grønbech-Jensen, M., Henriksen, O. A., et al. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00081-1 · Cited by 19
Future directions in research with presymptomatic individuals carrying the gene for Huntington’s disease
Georgiou‐Karistianis, N., Smith, E., Bradshaw, J. L., Chua, P. M.-L., Lloyd, J., Churchyard, A., & Chiu, E. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00877-8 · Cited by 19
Three Huntington’s Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes
Jacquet, L., Neueder, A., Foldes, G., Karagiannis, P., Hobbs, C., Jolinon, N., Mioulane, M., Sakai, T., Harding, S., & Ilic, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126860 · Cited by 20
Putting Huntingtin “Aggregation” in View with Windows into the Cellular Milieu
Hatters, D. M. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611212220013 · Cited by 18
Premanifest Huntington’s disease: Examination of oculomotor abnormalities in clinical practice
Winder, J. Y., & Roos, R. A. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193866 · Cited by 18
Characterization of Neurodevelopmental Abnormalities in iPSC-Derived Striatal Cultures from Patients with Huntington’s Disease
Mathkar, P. P., Suresh, D., Dunn, J., Tom, C. M., & Mattis, V. B. (2019) · Journal of Huntington s Disease · doi:10.3233/jhd-180333 · Cited by 18
A Study of Potential Interactive Genetic Factors in Huntington’s Disease
Panegyres, P. K., Beilby, J. P., Bulsara, M. K., Toufexis, K., & Wong, C. M. (2006) · European Neurology · doi:10.1159/000093867 · Cited by 18
Abnormal calcium metabolism in myotonic dystrophy as shown by the Ellsworth-Howard test and its relation to CTG triplet repeat length
Kinoshita, M., Komori, T., Ohtake, T., Takahashi, R., Nagasawa, R., & Hirose, K. (1997) · Journal of Neurology · doi:10.1007/s004150050155 · Cited by 18
Maternal transmission in sporadic Huntington's disease.
Sánchez, A., Milà, M., Castellvı́-Bel, S., Rosich-Estragó, M., Jiménez, D., Bádenas, C., & Estivill, X. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.5.535 · Cited by 18
Nonisotopic method for accurate detection of (CAG)n repeats causing Huntington disease
Muglia, M., Leone, O., Annesi, G., Gabriele, A. L., Imbrogno, E., Grandinetti, C., Conforti, F. L., Naso, F., & Brancati, C. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.10.1601 · Cited by 18
Patients' rights to laboratory data: Trinucleotide repeat length in Huntington disease
Burgess, M., & Hayden, M. R. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960301)62:1 · Cited by 18
Possibilities and challenges of small molecule organic compounds for the treatment of repeat diseases
Nakatani, K. (2022) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.98.003 · Cited by 21
Nanomedicine-Based Neuroprotective Strategies in Patient Specific-iPSC and Personalized Medicine
Jang, S.-F., Liu, W., Song, W.-S., Chiang, K.-L., Ma, H.-I., Kao, C.-L., & Chen, M.-T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033904 · Cited by 17
pBACode: a random-barcode-based high-throughput approach for BAC paired-end sequencing and physical clone mapping
Wei, X., Xu, Z., Wang, G., Hou, J., Ma, X., Liu, H., Liu, J., Chen, B., Luo, M., Xie, B., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1261 · Cited by 17
Optimization of trans-Splicing for Huntington's Disease RNA Therapy
Rindt, H., Tom, C. M., Lorson, C. L., & Mattis, V. B. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00544 · Cited by 18
Association Between Toll‐Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Genetic Variants and Clinical Progression of Huntington's Disease
Vuono, R., Kouli, A., Legault, E. M., Chagnon, L., Allinson, K. S. J., Spada, A., REGISTRY Investigators of the European Huntington's Disease Network, Biunno, I., Barker, R. A., & Drouin‐Ouellet, J. (2019) · Movement Disorders · doi:10.1002/mds.27911 · Cited by 17
CAG-Expansion Haplotype Analysis in a Population with a Low Prevalence of Huntington's Disease
Pulkes, T., Papsing, C., Wattanapokayakit, S., & Mahasirimongkol, S. (2014) · Journal of Clinical Neurology · doi:10.3988/jcn.2014.10.1.32 · Cited by 17
Length variation of CAG/CAA triplet repeats in 50 genes among 16 inbred mouse strains
Ogasawara, M., Imanishi, T., Moriwaki, K., Gaudieri, S., Tsuda, H., Hashimoto, H., Shiroishi, T., Gojobori, T., & Koide, T. (2005) · Gene · doi:10.1016/j.gene.2004.11.050 · Cited by 17
Genes with triplet repeats: a new class of mutations causing neurological diseases
Plassart, E., & Fontaine, B. (1994) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(94)90133-3 · Cited by 16
X-linked muscular atrophy and the androgen receptor
Trifiro, M. A., Kazemi‐Esfarjani, P., & Pinsky, L. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(95)92524-m · Cited by 17
Huntington’s Disease: Recent Advances in Diagnosis and Management
Furtado, S., & Suchowersky, O. (1995) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100040427 · Cited by 17
Rapamycin reduces neuronal mutant huntingtin aggregation and ameliorates locomotor performance in Drosophila
Roth, J. R., Moraes, R. C. M. D., Xu, B. P., Crawley, S. R., Khan, M. A., & Melkani, G. C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1223911 · Cited by 16
Vitamin B6, B12 and folate modulate deregulated pathways and protein aggregation in yeast model of Huntington disease
Pradhan, S. S., Rao, K. R., Manjunath, M., Saiswaroop, R., Patnana, D. P., Kanikaram, S. P., Choudhary, B., & Sivaramakrishnan, V. (2023) · 3 Biotech · doi:10.1007/s13205-023-03525-y · Cited by 16
Mechanisms underlying phenotypic variation in neurogenetic disorders
Burgunder, J. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00811-4 · Cited by 17
Loss of angiogenin function is related to earlier ALS onset and a paradoxical increase in ALS duration
Aluri, K. C., Salisbury, J. P., Prehn, J. H. M., & Agar, J. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-60431-6 · Cited by 16
Huntington's disease
Bonelli, R. M., & Beal, M. F. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00030-9 · Cited by 16
Disorders of higher gaze control
Kennard, C. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52903-9.00020-0 · Cited by 17
Case of maternally transmitted juvenile Huntington's disease with a very large trinucleotide repeat
Papapetropoulos, S., Lopez-Alberola, R., Baumbach, L. L., Russell, A. J., Gonzalez, M. A., Bowen, B. C., & Singer, C. (2005) · Movement Disorders · doi:10.1002/mds.20557 · Cited by 16
Coherent states as consequences of keto‐amino→ enol‐imine hydrogen bond arrangements driven by quantum uncertainty limits on amino DNA protons
Cooper, W. G. (2012) · International Journal of Quantum Chemistry · doi:10.1002/qua.22834 · Cited by 16
The search for cerebral biomarkers of Huntington's disease: a review of genetic models of age at onset prediction
Squitieri, F., Ciarmiello, A., Donato, S. D., & Frati, L. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01264.x · Cited by 16
Trinucleotide repeat expansion and human disease
Hummerich, H., & Lehrach, H. (1995) · Electrophoresis · doi:10.1002/elps.11501601282 · Cited by 16
Dynamic mutations in human genes: A review of trinucleotide repeat diseases
Longshore, J. W., & Tarleton, J. C. (1996) · Journal of Genetics · doi:10.1007/bf02931762 · Cited by 16
Minimal prevalence of Huntington’s disease in the South of Brazil and instability of the expanded CAG tract during intergenerational transmissions
Castilhos, R. M., dos Santos, J. A., Augustin, M. C., Pedroso, J. L., Barsottini, O. G. P., Saba, R. A., Ferraz, H. B., Godeiro-Junior, C. D. O., Vargas, F. R., Salarini, D. Z., et al. (2019) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2018-0032 · Cited by 14
G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials
Bellver‐Sanchís, A., Ribalta‐Vilella, M., Irisarri, A., Gehlot, P., Choudhary, B. S., Jana, A., Vyas, V. K., Banerjee, D. R., Pallàs, M., Guerrero, A., et al. (2025) · Medicinal Research Reviews · doi:10.1002/med.22096 · Cited by 14
Neuronal aggregates are associated with phenotypic onset in the R6/2 Huntington's disease transgenic mouse
Cowin, R.-M., Roscic, A., Bui, N., Graham, D. F., Paganetti, P., Jankowsky, J. L., Weiss, A., & Paylor, R. E. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.045 · Cited by 15
Male sexual function in presymptomatic gene carriers and patients with Huntington's disease
Kolenc, M., Kobal, J., & Podnar, S. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.11.015 · Cited by 16
Fluorescence Probe for Detecting CCG Trinucleotide Repeat DNA Expansion and Slip‐Out
Shibata, T., & Nakatani, K. (2016) · ChemBioChem · doi:10.1002/cbic.201600200 · Cited by 15
The struggle by Caenorhabditis elegans to maintain proteostasis during aging and disease
Kikis, E. A. (2016) · Biology Direct · doi:10.1186/s13062-016-0161-2 · Cited by 17
A Genetic Study of Psychosis in Huntington’s Disease: Evidence for the Involvement of Glutamate Signaling Pathways
Tsuang, D. W., Greenwood, T. A., Jayadev, S., Davis, M. Y., Shutes‐David, A., & Bird, T. D. (2018) · Journal of Huntington s Disease · doi:10.3233/jhd-170277 · Cited by 15
Introduction to Neurogenetics
Vgontzas, A., & Renthal, W. R. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.07.041 · Cited by 15
New insights into neural networks of error monitoring and clinical implications: a systematic review of ERP studies in neurological diseases
Lenzoni, S., Baker, J., Sumich, A. L., & Mograbi, D. C. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0054 · Cited by 15
Current Pharmacological Management in Juvenile Huntington’s Disease
Robertson, L., Santini, H., O’Donovan, K., Squitieri, F., Barker, R. A., Rakowicz, M. J., Landwehrmeyer, G. B., & Quarrell, O. (2012) · PLoS Currents · doi:10.1371/currents.rrn1304 · Cited by 15
Exploiting Yeast Genetics to Inform Therapeutic Strategies for Huntington’s Disease
Giorgini, F., & Muchowski, P. J. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-540-4_9 · Cited by 15
Clinical features of Chinese patients with Huntington's disease carrying CAG repeats beyond 60 within HTT gene
Liu, Z. ‐., Sun, Y., Wang, N., Dong, Y., Shi, S., & Wu, Z. (2013) · Clinical Genetics · doi:10.1111/cge.12120 · Cited by 15
Late-onset and typical Huntington disease families from Crete have distinct genetic origins
Kartsaki, E., Spanaki, C., Tzagournissakis, M., Petsakou, A., Moschonas, N. Κ., MacDonald, M. E., & Plaitakis, A. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.2.335 · Cited by 15
Self-citation
Optimising occupational performance through sensory modulation interventions: Case reports of two young adults diagnosed with juvenile Huntington's disease
Brown, A., & Fisher, C. A. (2015) · British Journal of Occupational Therapy · doi:10.1177/0308022615569249 · Cited by 17
Premanifest and Early Huntington’s Disease
Wild, E. J., & Tabrizi, S. J. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199929146.003.0005 · Cited by 16
Advances in Huntington’s disease: implications for experimental therapeutics
Feigin, A. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199808000-00012 · Cited by 15
Fragile X and other trinucleotide repeat diseases
Wenstrom, K. D. (2002) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(01)00005-5 · Cited by 15
Limited Expansion of the (CAG)n Repeat of the Huntington Gene: A Premutation (?)
Legius, E., Cuppens, H., Dierick, H. A., Zandt, K., Dom, R., Fryns, J. P., Evers‐Kiebooms, G., Decruyenaere, M., Demyttenaere, K., Marynen, P., et al. (1994) · European Journal of Human Genetics · doi:10.1159/000472340 · Cited by 15
Single-stranded DNA binding proteins isolated from mouse brain recornize specific trinucleotide repeat sequencesin vitro
Yano-Yanagisawa, H., Yin, L., Wang, H., & Kohwi, Y. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.14.2654 · Cited by 15
Suppression of Huntington’s Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding
Mathews, E. W., Coffey, S. R., Gärtner, A., Belgrad, J., Bragg, R. M., O’Reilly, D., Cantle, J. P., McHugh, C. A., Summers, A., Fentz, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64936-4 · Cited by 14
Neurological Proteins Are Not Enriched For Repetitive Sequences
Huntley, M. A., & Golding, G. B. (2004) · Genetics · doi:10.1534/genetics.166.3.1141 · Cited by 14
A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis
Lee, Y. H., Tsai, Y., Chang, C., Ho, C.-C., Shih, H., Chen, H., Lai, H., Lee, C., Lee, Y., Liao, Y., et al. (2021) · Movement Disorders · doi:10.1002/mds.28896 · Cited by 14
mRNA isoform balance in neuronal development and disease
LaForce, G. R., Philippidou, P., & Schaffer, A. E. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1762 · Cited by 15
Linkage Disequilibrium between the Expanded (CAG)(n) Repeat and an Allele of the Adjacent (CCG)(n) Repeat in Huntington's Disease Patients of Greek Origin
Yapijakis, C., Vassilopoulos, D., Tzagournissakis, M., Maris, T. G., Fesdjian, C. O., Papageorgiou, C., & Plaitakis, A. (1995) · European Journal of Human Genetics · doi:10.1159/000472303 · Cited by 14
Use of capillary electrophoresis for accurate determination of CAG repeats causing Huntington disease. An oligonucleotide design avoiding shadow bands
Blanco, S., Suárez, A., Gandia‐Pla, S., Gómez‐Llorente, C., Antúnez, A., Gómez‐Capilla, J. A., & Fárez‐Vidal, M. E. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510801915171 · Cited by 14
Molecular Genetics of Huntington’s Disease
MacDonald, M. E. (1998) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69680-3_2 · Cited by 14
Self-citation
Regenerative medicine in Huntington’s disease: Strengths and weaknesses of preclinical studies
Tartaglione, A. M., Popoli, P., & Calamandrei, G. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.017 · Cited by 14
Dynamic Prediction of Motor Diagnosis in Huntington’s Disease Using a Joint Modeling Approach
Li, K., The PREDICT-HD Investigators of the Huntington Study Group, Furr-Stimming, E. E., Paulsen, J. S., & Luo, S. (2017) · Journal of Huntington s Disease · doi:10.3233/jhd-170236 · Cited by 14
Role of Phosphorylated Tau and Glucose Synthase Kinase 3 Beta in Huntington’s Disease Progression
Sawant, N. A., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190851 · Cited by 14
Progressive CAG expansion in the brain of a novel R6/1-89Q mouse model of Huntington's disease with delayed phenotypic onset
Vatsavayai, S. C., Dallérac, G. M., Milnerwood, A. J., Cummings, D. M., Rezaie, P., Murphy, K., & Hirst, M. C. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.10.015 · Cited by 14
Variability in cognitive function among persons at high genetic risk of Huntington's disease
Lundervold, A. J., & Reinvang, I. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb00447.x · Cited by 14
Huntington's disease
Craufurd, D. (1996) · Prenatal Diagnosis · doi:10.1002/(sici)1097-0223(199612)16:13 · Cited by 14
Identification and Chromosomal Localization of Human Genes Containing CAG/CTG Repeats Expressed in Testis and BrainPreprint
Bulle, F., Chiannilkulchai, N., Pawlak, A., Weissenbach, J., Gyapay, G., & Guellaën, G. (1997) · Genome Research · doi:10.1101/gr.7.7.705 · Cited by 14
Loss of FIC-1-mediated AMPylation activates the UPRER and upregulates cytosolic HSP70 chaperones to suppress polyglutamine toxicity
Pelt, K. M. V., & Truttmann, M. C. (2025) · PLoS Genetics · doi:10.1371/journal.pgen.1011723 · Cited by 13
N-terminal mutant huntingtin deposition correlates with CAG repeat length and symptom onset, but not neuronal loss in Huntington's disease
Layburn, F., Tan, A. Y. S., Mehrabi, N. F., Curtis, M. A., Tippett, L. J., Turner, C. P., Riguet, N., Aeschbach, L., Lashuel, H. A., Dragunow, M., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105884 · Cited by 15
Loss of TDP-43 promotes somatic CAG repeat expansion in Huntington’s disease knock-in mice
Bai, D., Zhu, L., Jia, Q., Duan, X., Chen, L., Wang, X., Hou, J., Jiang, G., Yang, S., Li, S., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102484 · Cited by 13
Modification of Huntington’s disease by short tandem repeats
Hong, E. P., Ramos, E. M., Aziz, N. A., Massey, T. H., McAllister, B., Lobanov, S. V., Jones, L., Holmans, P., Kwak, S., Orth, M., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae016 · Cited by 13
Self-citation
Huntington’s Disease in Israel: A Population-Based Study Using 20 Years of Routinely-Collected Healthcare Data
Gavrielov‐Yusim, N., Barer, Y., Martinec, M., Siadimas, A., Roumpanis, S., Furby, H., Goldshtein, I., Jan, A., & Coloma, P. M. (2021) · Journal of Huntington s Disease · doi:10.3233/jhd-210500 · Cited by 13
Reprint of: Manipulation of microbiota reveals altered callosal myelination and white matter plasticity in a model of Huntington disease
Radulescu, C. I., Garcia‐Miralles, M., Sidik, H., Bardile, C. F., Yusof, N. A. B. M., Lee, H. U., Ho, E. X. P., Chu, C. W., Layton, E., Low, D., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104744 · Cited by 13
Novel mutations associated with carnitine palmitoyltransferase II deficiency
Taggart, R. T., Smail, D., Apolito, C. J., & Vladutiu, G. D. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)13:3 · Cited by 90
Female Sexual Dysfunction in Presymptomatic Mutation Carriers and Patients with Huntington’s Disease
Kolenc, M., Kobal, J., & Podnar, S. (2017) · Journal of Huntington s Disease · doi:10.3233/jhd-160224 · Cited by 13
Epigenetic and transcriptional modulation of WDR5 , a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model
Baronchelli, S., Spada, A., Ntai, A., Barbieri, A., Conforti, P., Jotti, G. S., Redaelli, S., Bentivegna, A., Blasio, P. D., & Biunno, I. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.04.013 · Cited by 13
The Differential Susceptibility of Specific Neuronal Populations: Insights from Huntington's Disease
Mitchell, I., & Griffiths, M. (2003) · IUBMB Life · doi:10.1080/1521654031000153012 · Cited by 13
Eye–head coordination in moderately affected Huntington’s Disease patients: do head movements facilitate gaze shifts?
Becker, W., Jürgens, R., Kassubek, J., Ecker, D., Kramer, B., & Landwehrmeyer, G. B. (2008) · Experimental Brain Research · doi:10.1007/s00221-008-1559-6 · Cited by 13
Posttranscriptional regulation of FAN1 by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington’s disease
Kim, K., Hong, E. P., Lee, Y., McLean, Z. L., Elezi, E., Lee, R., Kwak, S., McAllister, B., Massey, T. H., Lobanov, S. V., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2322924121 · Cited by 11
Self-citation
Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease
Clemensson, E. K. H., Clemensson, L. E., Fabry, B., Rieß, O., & Nguyen, H. P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173232 · Cited by 14
Tandem Repeats Contribute to Coding Sequence Variation in Bumblebees (Hymenoptera: Apidae)
Zhao, X., Su, L., Schaack, S., Sadd, B. M., & Sun, C. (2018) · Genome Biology and Evolution · doi:10.1093/gbe/evy244 · Cited by 12
Cytotoxicity models of Huntington’s disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies
Calabrese, E. J., Bhatia, T. N., Calabrese, V., Dhawan, G., Giordano, J., Hanekamp, Y. N., Kapoor, R., Kozumbo, W. J., & Leak, R. K. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104371 · Cited by 12
Locomotion et maladie de Huntington
Delval, A., & Krystkowiak, P. C. (2009) · Revue Neurologique · doi:10.1016/j.neurol.2009.05.013 · Cited by 12
The Complexity of Clinical Huntington’s Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers
Tippett, L. J., Waldvogel, H. J., Snell, R. G., Vonsattel, J., Young, A. B., & Faull, R. L. M. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_5 · Cited by 12
Self-citation
Predictive testing for Huntington disease over 24 years: Evolution of the profile of the participants and analysis of symptoms
Ramond, F., Quadrio, I., Vavasseur, L. L., Chaumet, H., Boyer, F., Bost, M., & Ollagnon‐Roman, E. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.881 · Cited by 12
Huntington’s Disease
Pender, N. P., & Koroshetz, W. J. (2011) · Springer eBooks · doi:10.1007/978-1-84996-011-3_8 · Cited by 11
Self-citation

Authors: Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., Gray, J., Conneally, P., Young, A., Penney, J., Hollingsworth, Z., Shoulson, I., Lazzarini, A., Falek, A., Koroshetz, W., Sax, D., Bird, E., Vonsattel, J., Bonilla, E., Alvir, J., Bickham Conde, J., Cha, J.-H., Dure, L., Gomez, F., Ramos, M., Sanchez-Ramos, J., Snodgrass, S., de Young, M., Wexler, N., Moscowitz, C., Penchaszadeh, G., MacFarlane, H., Anderson, M., Jenkins, B., Srinidhi, J., Barnes, G., Gusella, J., & MacDonald, M.
Affiliations: Massachusetts General Hospital (US)
Boston University (US)
University of Rome Tor Vergata (IT)
Johns Hopkins University (US)
Indiana University (US)
University of Rochester Medicine (US)
Rutgers, The State University of New Jersey (US)
Emory University (US)
Harvard University (US)
Universidad del Zulia (VE)
Long Island Jewish Medical Center (US)
Kennedy Krieger Institute (US)
Hospital Virgen del Camino (ES)
University of Mississippi Medical Center (US)
Hereditary Disease Foundation (US)
ORCID: Myers, R.
Novelletto, A.
Persichetti, F.
Frontali, M.
Ross, C.
Shoulson, I.
Koroshetz, W.
Bonilla, E.
Dure, L.
Snodgrass, S.
Wexler, N.
Gusella, J.
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 1993-08
Volume: 4
Issue: 4
Pages: 387-392
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng0893-387
OpenAlex: W1994285647
Cited by: 1,089
References: 35
Citations by year: 2026: 17 · 2025: 27 · 2024: 37 · 2023: 23 · 2022: 39 · 2021: 42 · 2020: 36 · 2019: 38 · 2018: 35 · 2017: 42 · 2016: 26 · 2015: 35 · 2014: 31 · 2013: 39 · 2012: 47
FWCI: 17.83
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ns017978-06)
National Institute of Neurological Disorders and Stroke (NS17978, NS16375, NS 16367)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords: Huntington's disease, trinucleotide repeat expansion, repeat instability, age of onset, paternal transmission, spermatogenesis, presymptomatic diagnosis, repeat length
MeSH terms: Adult, Age Factors, Female, Genetic Carrier Screening, Humans, Huntington Disease, Genetic Linkage, Male, Middle Aged, Pedigree, Repetitive Sequences, Nucleic Acid, Spermatozoa, Linkage Disequilibrium

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Trinucleotide repeat length instability and age of onset in Huntington's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks